Durect Corp

NASDAQ:DRRX

1.87

-0.01 (-0.53%)

6:08:05 PM EDT: $1.85 -0.02 (-1.07%)

Market Cap (Intraday)	57.74M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.31 Million
Adjusted EPS	-$0.12

See more estimates

10-Day MA	$1.65
50-Day MA	$0.83
200-Day MA	$0.85

See more pivots

Durect Corp Stock, NASDAQ:DRRX

10240 Bubb Road, Cupertino, California 95014-4166

United States of America

Phone: +1.408.777.1417

Number of Employees: 58

http://www.durect.com

Description

DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.